Evidence map›Paper›PMID 36314388›Full record

ArticleThe British journal of radiology2023

Women's perceptions and attitudes to the use of AI in breast cancer screening: a survey in a cancer referral centre.

Filippo Pesapane, Anna Rotili, Elena Valconi, Giorgio Maria Agazzi, Marta Montesano, Silvia Penco, Luca Nicosia, Anna Bozzini, Lorenza Meneghetti, Antuono Latronico and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The British journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Filippo PesapaneBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-0374-5054
Anna RotiliBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Elena ValconiDiagnostic and Interventional Radiology Unit, Department of Diagnostic and Therapeutic Advanced Technology, Azienda Socio Sanitaria Territoriale Santi Paolo and Carlo Hospital, Milan, Italy.
Giorgio Maria AgazziDiagnostic and Interventional Radiology Unit, Department of Diagnostic and Therapeutic Advanced Technology, Azienda Socio Sanitaria Territoriale Santi Paolo and Carlo Hospital, Milan, Italy.
Marta MontesanoBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Silvia PencoBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Luca NicosiaBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Anna BozziniBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Lorenza MeneghettiBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Antuono LatronicoBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Maria PizzamiglioBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Eleonora RosseroLaboratorio dei Diritti Fondamentali, Collegio Carlo Alberto, Torino ER, Turin, Italy.
Aurora GaetaDepartment of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Sara RaimondiDepartment of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Silvia Francesca Maria PizzoliDipartimento di Oncologia ed Emato Oncologia, Università degli studi di Milano, Milan, Italy.
Roberto GrassoApplied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy.
Gianpaolo CarrafielloDepartment of Radiology and Department of Health Sciences, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milano, Milan, Italy.
Gabriella PravettoniBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
Enrico CassanoBreast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy.
European Institute of Oncology · ITCollegio Carlo Alberto · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough breast cancer screening can benefit from Artificial Intelligence (AI), it is still unknown whether, to which extent or under which conditions, the use of AI is going to be accepted by the general population. The aim of our study is to evaluate what the females who are eligible for breast cancer screening know about AI and how they perceive such innovation.

methodsWe used a prospective survey consisting of a 11-multiple-choice questionnaire evaluating statistical associations with Chi-Square-test or Fisher-exact-test. Multinomial-logistic-regression was performed on items with more than two response categories. Odds ratio (OR) with 95% CI were computed to estimate the probability of a specific response according to patient's characteristics.

resultsIn the 800 analysed questionnaires, 51% of respondents confirmed to have knowledge of AI. Of these, 88% expressed a positive opinion about its use in medicine. Non-Italian respondents were associated with the belief of having a deep awareness about AI more often than Italian respondents (OR = 1.91;95% CI[1.10-3.33]). Higher education level was associated with better opinions on the use of AI in medicine (OR = 4.69;95% CI[1.36-16.12]). According to 94% of respondents, the radiologists should always produce their own report on mammograms, whilst 77% agreed that AI should be used as a second reader. Most respondents (52%) considered that both the software developer and the radiologist should be held accountable for AI errors.

conclusionsMost of the females undergoing screening in our Institute approve the introduction of AI, although only as a support to radiologist, and not in substitution thereof. Yet, accountability in case of AI errors is still unsolved. advances in knowledge:This survey may be considered as a pilot-study for the development of large-scale studies to understand females's demands and concerns about AI applications in breast cancer screening.

Indexed as

Breast NeoplasmsEarly Detection of CancerArtificial IntelligenceFemaleHumansMammographyPilot ProjectsProspective StudiesReferral and ConsultationSurveys and Questionnaires

Identifiers

PMID36314388
PMCPMC11864346
OpenAlexW4307777113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.